SCHEMBL30432974

SCHEMBL30432974

COc1nc2ccccn2c(=O)c1CNC[C@H](C)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.44
▸ GAA P10253 3/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ MAPT P10636 1/20 0.43
▸ PDCD1LG2 Q9BQ51 2/20 0.41
▸ CD274 Q9NZQ7 2/20 0.41
▸ HSD17B10 Q99714 4/20 0.39
▸ CASP1 P29466 3/20 0.39
▸ CASP7 P55210 3/20 0.39
▸ ALDH1A1 P00352 5/20 0.39
▸ ELANE P08246 2/20 0.39
▸ ENPP2 Q13822 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ TSHR P16473 2/20 0.39
▸ HTR6 P50406 1/20 0.38
▸ GLA P06280 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ DAPK3 O43293 1/20 0.38
▸ JAK2 O60674 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30431887 0.85 ENPP2 (0.52) KDM4EGAARAB9AMAPTHSD17B10
SCHEMBL30432662 0.78 ALDH1A1 (0.46) KDM4EGAARAB9AMAPTHSD17B10
SCHEMBL30433046 0.75 ALDH1A1 (0.47) KDM4EGAARAB9AMAPTHSD17B10
SCHEMBL30433994 0.74 RXFP1 (0.52) KDM4EALDH1A1PKMHTT
SCHEMBL30432671 0.74 RXFP1 (0.52) KDM4EALDH1A1PKMHTT
SCHEMBL10201502 0.69 ELANE (0.52) KDM4EGAARAB9AMAPTHSD17B10
SCHEMBL3955341 0.69 ELANE (0.48) KDM4EGAARAB9AMAPTHSD17B10
SCHEMBL2227475 0.67 MAPT (0.52) KDM4EGAARAB9AMAPTALDH1A1
SCHEMBL14552747 0.65 USP7 (0.49) KDM4EGAAMAPTHSD17B10CASP1
SCHEMBL2228484 0.65 MAPT (0.44) KDM4EGAARAB9AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (US) 2023-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME HAVCR2, HMBS, VHL KDM4E 224/4885GAA 1601/4885RAB9A 1781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback